Healthcare & Pharmaceuticals

Published by
Special to CorpWatch
|
By |
Almost four years after the toppling of Saddam Hussein, Iraq's healthcare system is still a shambles. While most hospitals lack basic supplies, dozens of incomplete clinics and warehoused high-technology equipment remain as a testament to the failed U.S. experiment to reconstruct of Iraq. First in a series of CorpWatch articles. Read More
Published by
Chicago Sun-Times
|
By |
It happens only once a year, and yet so many headstrong corporate CEO's can't seem to cope with being in a room with shareholders for a few hours at the annual meeting. Read More
Published by
The New York Times
|
By |
Early in March, Bausch & Lomb received a troubling phone call from a New Jersey eye doctor. Dr. David S. Chu, a specialist in cornea diseases, alerted the company that three of his recent patients had been afflicted with a microbe that caused a potentially blinding eye infection. Read More
Published by
Inter Press Service News Agency
|
By |
Two patents granted in the United States between 2000 and 2002 and another for which an application has been filed have put "maca", a high altitude Andean plant that is used by indigenous people in Peru, at the centre of a new battle against biopiracy, which involves the construction of an international network against the misappropriation of traditional knowledge. Read More
Published by
The New York Times
|
By |
A Congressional investigation of the money that drug companies give as supposed educational grants has found that the payments are growing rapidly and are sometimes steered by marketing executives to doctors and groups who push unapproved uses of drugs. Read More
Published by
The New York Times
|
By |
The Food and Drug Administration yesterday released a warning letter it sent to the Guidant Corporation, restricting the ability of the company to win approval for some new medical products. In the letter, sent a week ago, the agency said Guidant, the heart device maker, had not fully responded to its concerns about manufacturing procedures at the company's biggest plant. Read More
Published by
The New York Times
|
By |
LOS ANGELES, Aug. 25 - The attorney general of California sued 39 drug companies on Thursday, accusing them of bilking the state of hundreds of millions of dollars by overcharging for medicines. Read More
* indicates required